Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell―Based Vaccination in Metastatic MelanomaAARNTZEN, Erik H. J. G; BOL, Kalijn; SCHREIBELT, Gerty et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 23, pp 6102-6110, issn 0008-5472, 9 p.Article

Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma MetastasisWEIDE, Benjamin; ZELBA, Henning; SCHADENDORF, Dirk et al.Journal of clinical oncology. 2012, Vol 30, Num 15, pp 1835-1841, issn 0732-183X, 7 p.Article

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma PatientsTEL, Jurjen; AARNTZEN, Erik H. J. G; WINKELS, Gregor et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 3, pp 1063-1075, issn 0008-5472, 13 p.Article

Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parametersAARNTZEN, Erik H. J. G; JOLANDA, I; TACKEN, Paul J et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 11, pp 2003-2011, issn 0340-7004, 9 p.Article

Route of Administration Modulates the Induction of Dendritic Cell Vaccine―Induced Antigen-Specific T Cells in Advanced Melanoma PatientsJOOST LESTERHUIS, W; DE VRIES, I. Jolanda M; VAN ROSSUM, Michelle M et al.Clinical cancer research (Print). 2011, Vol 17, Num 17, pp 5725-5735, issn 1078-0432, 11 p.Article

In situ Expression of Tumor Antigens by Messenger RNA―Electroporated Dendritic Cells in Lymph Nodes of Melanoma PatientsSCHUURHUIS, Danita H; VERDIJK, Pauline; BONENKAMP, Johannes J et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 7, pp 2927-2934, issn 0008-5472, 8 p.Article

Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma PatientsVERDIJK, Pauline; AARNTZEN, Erik H. J. G; BLOKX, Willeke et al.Clinical cancer research (Print). 2009, Vol 15, Num 7, pp 2531-2540, issn 1078-0432, 10 p.Article

Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cellsSCHUURHUIS, Danita H; LESTERHUIS, W. Joost; PUNT, Cornelis J. A et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 7, pp 1109-1115, issn 0340-7004, 7 p.Article

Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patientsJACOBS, Joannes F. M; AARNTZEN, Erik H. J. G; DE VRIES, I. Jolanda M et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 1, pp 145-151, issn 0340-7004, 7 p.Article